Microarray expression profiling data for Trp53/Brca1-null mammary tumors derived from K8+ luminal cells. Microarray expression profiling data for Trp53/Brca1-null mammary tumors derived from K8+ luminal cells

BRCA1 mutation-carriers are predisposed to develop Basal-like breast cancer (BLBC), and p53 mutations are present in the majority of human BLBC cases, suggesting loss of these two tumor suppressors play key roles in development of BLBC. Recent studies suggest that the majority of human breast cancers, including BLBC, may originate from mammary epithelial cells (MECs) in the luminal lineage. However, how loss of p53 and BRCA1 contributes to development of BLBC from luminal MECs remains largely elusive. We developed a novel genetic targeting and lineage tracing approach based on intraductal injection of Cre-expressing adenovirus under the control of the pan-luminal Keratin 8 (K8) promoter (Ad-K8-Cre). We performed intraductal injection of Ad-K8-Cre to female mice carrying conditional knockout alleles of Brca1 and Trp53. The injected females developed mammary tumors within 12 months after injection. Microarray expression profiling of these tumors showed that they most closely resembled human BLBC. Overall design: Total RNAs from YFP+ wild-type luminal mammary epithelial cells (i.e., cells of origin) sorted from Rosa26-Stop-YFP female mice 10-14 days after intraductal induction of Ad-K8-Cre adenovirus, or from mammary tumors developed in Trp53L/L;Brca1L/L females several months after intraductal injection of Ad-K8-Cre, were prepared and subjected to microarray expression profiling.